Mindfulness-Enhanced Dual-Task Training in PD-MCI
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-75
SponsorNanjing Mingzhou Rehabilitation Hospital
About this trial
The goal of this clinical trial is to learn if Mindfulness-Enhanced Dual-Task Training work to treat PD-MCI in adults. The main questions it aims to answer are:
Does Mindfulness-Enhanced Dual-Task Training improve the cognitive or motor function of participants? Can the combination of Dual-Task Training and Mindfulness achieve better effects?
Researchers will compare 3 groups (Dual-Task Training + Mindfulness, Dual-Task Training, and conventional motor task training) to see if Dual-Task Training and Mindfulness works to treat PD-MCI.
Participants will:
Receive treatment for 4 weeks Receive scale and instrument testing before and after treatment
Eligibility criteria
Qualifiers
Age: Between 55 and 75 years.
Disease Diagnosis: Clinically diagnosed with Idiopathic Parkinson's Disease (PD) according to the UK Parkinson's Disease Society Brain Bank Criteria.
Disease Stage: Hoehn & Yahr (H&Y) stages 1 to 2.5.
Cognitive Function: Montreal Cognitive Assessment (MoCA) score between 23 and 26, indicating mild cognitive impairment (MCI).
Disqualifiers
Other Neurological Disorders: Presence of other neurological conditions that could affect cognitive function, such as Alzheimer's disease, stroke, or brain tumors.
Psychiatric Conditions: Severe psychiatric disorders, including major depressive disorder or schizophrenia.
Substance Abuse: Recent history of drug or alcohol abuse.
Serious Medical Conditions: Uncontrolled hypertension, diabetes, heart disease, or other conditions that could interfere with study participation or outcomes.
Trial design
Treatments tested in this trial
- Cognitive-Motor Dual-Task Training
- Mindfulness Training
- Single-task Training
- Quiet Rest
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov